Company: PCRX
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001628280-25-050176
Chunk: 76

Company: Pacira BioSciences, Inc.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 76
---
 card receivables, investment grade commercial paper and corporate, federal agency, government and Yankee bonds with maturities greater than three months, but less than one year. Net unrealized gains and losses (excluding credit losses, if any) from the Company’s short-term investments are reported in other comprehensive income (loss). At September 30, 2025 and December 31, 2024, all of the Company’s short-term investments are classified as available-for-sale investments and are determined to be Level 2 instruments, with the exception of U.S. government bonds, which are measured at fair value using standard industry models with observable inputs. The fair value of the commercial paper is measured based on a standard industry model that uses the three-month U.S. Treasury bill rate as an observable input. The fair value of the asset-backed securities and corporate bonds is principally measured or corroborated by trade data for identical issues in which related trading activity is not sufficiently frequent to be considered a Level 1 input or that of comparable securities. The fair value of U.S. government bonds is based on level 1 trading activity. At the time of purchase, all available-for-sale investments had an “A” or better rating by Standard & Poor’s. The following summarizes the Company’s short-term available-for-sale investments at September 30, 2025 and December 31, 2024 (in thousands):September 30, 2025 InvestmentsCostGrossUnrealizedGainsGrossUnrealizedLossesFair Value(Level 2)Current:Asset-backed securities$8,520 $2 $— $8,522 Commercial paper57,292 8 (9)57,291 Corporate bonds32,918 16 (2)32,932           Total$98,730 $26 $(11)$98,745 December 31, 2024 InvestmentsCostGrossUnrealizedGainsGrossUnrealizedLossesFair Value(Level 2)Current:Asset-backed securities$21,626 $43 $— $21,669 Commercial paper142,556 120 (55)142,621 Corporate bonds32,502 25 (5)32,522 U.S. federal agency bonds5,996 8 — 6,004 Yankee bond5,012 13 — 5,025           Total$207,692 $209 $(60)$207,